Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL.
Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL.
Am J Obstet Gynecol. 2018 Dec;219(6):608.e1-608.e7. doi: 10.1016/j.ajog.2018.08.039. Epub 2018 Aug 29.
More than half of patients hospitalized annually receive an opioid during their inpatient hospitalization, which may serve as a first opioid exposure. Although recent research addresses outpatient opioid prescribing following delivery, little is known regarding the extent to which opioids are used during the postpartum hospitalization following vaginal delivery.
Our objectives were as follows: (1) to describe the use of opioids during the last 24 hours of postpartum hospitalization in women following vaginal delivery and (2) to identify patient and provider characteristics associated with the use of opioids during this time period.
This is a retrospective case-control study of women who underwent vaginal delivery at a single tertiary care center from Dec. 1, 2015, to Nov. 30, 2016. Inpatient, pharmacy, and administrative records were queried for clinical and inpatient prescriber data. Opioid use during the last 24 hours of the postpartum hospitalization was determined. Significant factors on bivariable analysis were assessed in multivariable hierarchical logistic regression with random effects to identify patient and provider factors associated with any opioid use. A subgroup analysis of women who underwent an uncomplicated vaginal delivery, defined as lack of intrapartum, postpartum, or neonatal complications, was performed.
In this cohort of 9038 women after a vaginal delivery, almost a quarter (n = 2242, 24.8%) utilized opioids during the last 24 hours of the postpartum hospitalization. In a multivariable analysis, several patient characteristics were associated with increased odds of opioid use during the last 24 hours of admission, including higher body mass index, history of smoking and substance abuse, use of regional analgesia, vaginal birth after cesarean delivery, major laceration, postpartum hemorrhage, and infectious complication. Even after adjusting for these characteristics, greater use of acetaminophen (adjusted odds ratio, 0.81, 95% confidence interval, 0.77-0.85) and analgesia orders written by an advanced practitioner (adjusted odds ratio, 0.46, 95% confidence interval, 0.29-0.73) remained associated with decreased odds of using an opioid. The same 2 factors remained associated with less opioid use (acetaminophen doses [adjusted odds ratio, 0.86, 95% confidence interval, 0.81-0.92] and analgesia orders written by an advanced practitioner [adjusted odds ratio, 0.52, 95% confidence interval, 0.30-0.89]) when only women who had an uncomplicated vaginal delivery were analyzed.
In a large cohort, nearly one-quarter of women use opioid analgesia during the last 24 hours of inpatient hospitalization following vaginal delivery. Although patient factors account for some of the variation in inpatient opioid use, both use of acetaminophen and having had postpartum orders written by an advanced practitioner were independently associated with lower odds of inpatient opioid use.
每年有超过一半的住院患者在住院期间接受阿片类药物治疗,这可能是他们首次接触阿片类药物。尽管最近的研究涉及到分娩后门诊阿片类药物的处方,但对于阴道分娩后产妇住院期间阿片类药物的使用程度知之甚少。
我们的目的如下:(1)描述阴道分娩后产妇在住院最后 24 小时内使用阿片类药物的情况;(2)确定与该时期使用阿片类药物相关的患者和提供者特征。
这是一项回顾性病例对照研究,纳入了 2015 年 12 月 1 日至 2016 年 11 月 30 日在一家三级保健中心接受阴道分娩的女性。对住院、药房和行政记录进行查询,以获取临床和住院处方数据。确定了产妇在产后住院最后 24 小时内使用阿片类药物的情况。对单变量分析中具有统计学意义的因素进行多变量分层逻辑回归分析,采用随机效应识别与任何阿片类药物使用相关的患者和提供者因素。对经历了无并发症阴道分娩的女性(定义为无分娩、产后或新生儿并发症)进行了亚组分析。
在这项纳入 9038 名阴道分娩产妇的队列研究中,近四分之一(n=2242,24.8%)在产后住院最后 24 小时内使用了阿片类药物。在多变量分析中,一些患者特征与增加的阿片类药物使用几率相关,包括更高的体重指数、吸烟和药物滥用史、使用区域镇痛、剖宫产术后阴道分娩、严重裂伤、产后出血和感染性并发症。即使在调整了这些特征后,使用乙酰氨基酚(调整后的优势比,0.81,95%置信区间,0.77-0.85)和由高级从业者开具的镇痛医嘱(调整后的优势比,0.46,95%置信区间,0.29-0.73)仍然与使用阿片类药物的几率降低相关。同样的 2 个因素与较少使用阿片类药物(乙酰氨基酚剂量[调整后的优势比,0.86,95%置信区间,0.81-0.92]和由高级从业者开具的镇痛医嘱[调整后的优势比,0.52,95%置信区间,0.30-0.89])相关,当仅分析经历了无并发症阴道分娩的女性时。
在一项大型队列研究中,近四分之一的女性在阴道分娩后住院的最后 24 小时内使用阿片类药物进行镇痛。尽管患者因素在一定程度上解释了住院期间阿片类药物使用的差异,但使用乙酰氨基酚和由高级从业者开具的术后镇痛医嘱均与较低的住院期间阿片类药物使用几率独立相关。